1-22659523-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001378156.1(C1QB):c.61G>A(p.Asp21Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001378156.1 missense
Scores
Clinical Significance
Conservation
Publications
- C1Q deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QB | NM_001378156.1 | c.61G>A | p.Asp21Asn | missense_variant | Exon 2 of 3 | ENST00000509305.6 | NP_001365085.1 | |
C1QB | NM_000491.5 | c.67G>A | p.Asp23Asn | missense_variant | Exon 2 of 3 | NP_000482.3 | ||
C1QB | NM_001371184.3 | c.61G>A | p.Asp21Asn | missense_variant | Exon 3 of 4 | NP_001358113.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000796 AC: 20AN: 251312 AF XY: 0.0000957 show subpopulations
GnomAD4 exome AF: 0.0000376 AC: 55AN: 1461828Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727218 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74266 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.67G>A (p.D23N) alteration is located in exon 2 (coding exon 1) of the C1QB gene. This alteration results from a G to A substitution at nucleotide position 67, causing the aspartic acid (D) at amino acid position 23 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This variant has not been reported in the literature in individuals with C1QB-related conditions. This sequence change replaces aspartic acid with asparagine at codon 23 of the C1QB protein (p.Asp23Asn). The aspartic acid residue is weakly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs555943495, ExAC 0.02%). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
C1Q deficiency 2 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at